IDEXX Laboratories Inc
NASDAQ:IDXX
IDEXX Laboratories Inc
NASDAQ:IDXX
Price:
485.56 USD
0.39%
Updated:
May 8, 2024
IDEXX Laboratories Inc
Cash from Financing Activities
|
IDEXX Laboratories Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Cash from Financing Activities
-$440m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-14%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$6.9B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is IDEXX Laboratories Inc's Cash from Financing Activities?
Cash from Financing Activities
-440m
USD
-440m
USD
Based on the financial report for Mar 31, 2024, IDEXX Laboratories Inc's Cash from Financing Activities amounts to -440m USD.
What is IDEXX Laboratories Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-14%
-14%
Over the last year, the Cash from Financing Activities growth was 13%. The average annual Cash from Financing Activities growth rates for IDEXX Laboratories Inc have been -4% over the past three years , -10% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
